„It was a pleasure working with Eugenio during his internship. He demonstrated excellent research skills and quickly built a good knowledge of European market access and rare diseases. He quickly integrated himself into the team, and always took a proactive approach to learning and assisting on projects. “
Eugenio Rizzello
Basel, Basel, Schweiz
1165 Follower:innen
500+ Kontakte
Info
Eugenio Rizzello is a Senior Consultant at Alira Health with 6 years of experience in the…
Aktivitäten
-
Excited to share that our research on Circulating Tumor Cells has just been published in the Journal of Experimental & Clinical Cancer Research with…
Excited to share that our research on Circulating Tumor Cells has just been published in the Journal of Experimental & Clinical Cancer Research with…
Beliebt bei Eugenio Rizzello
-
Despite recent advances in medicine, rare diseases continue to represent a huge unmet medical need and a significant public health challenge. Of the…
Despite recent advances in medicine, rare diseases continue to represent a huge unmet medical need and a significant public health challenge. Of the…
Beliebt bei Eugenio Rizzello
-
Last month was a busy one for #TeamDolon and the social committee! We had the opportunity to welcome our latest cohort of new hires Ema Slapikaite…
Last month was a busy one for #TeamDolon and the social committee! We had the opportunity to welcome our latest cohort of new hires Ema Slapikaite…
Beliebt bei Eugenio Rizzello
Berufserfahrung
Ausbildung
-
-
–
Consulente e progettista di Sistemi di gestione per la sicurezza OHSAS 18001:2007 e D.Lgs. 81, consulente e progettista di Sistemi di gestione per la Qualità ISO 9001:20008, Consulente e progettista di Sistemi per la gestione dell'Energia ISO 50001:2011, Consulente e progettista di Sistemi di gestione Ambientali ISO 14001:2004, Lead Auditor di sistemi di gestione per la sicurezza OHSAS 18001:2007 (40 ore), Lead Auditor di Sistemi di gestione Qualità ISO 9001:2008 (40 ore), Lead Auditor di…
Consulente e progettista di Sistemi di gestione per la sicurezza OHSAS 18001:2007 e D.Lgs. 81, consulente e progettista di Sistemi di gestione per la Qualità ISO 9001:20008, Consulente e progettista di Sistemi per la gestione dell'Energia ISO 50001:2011, Consulente e progettista di Sistemi di gestione Ambientali ISO 14001:2004, Lead Auditor di sistemi di gestione per la sicurezza OHSAS 18001:2007 (40 ore), Lead Auditor di Sistemi di gestione Qualità ISO 9001:2008 (40 ore), Lead Auditor di Sitemi di gestione Ambientali ISO 14001:2004 (40 ore), Auditor di sistemi di gestione dell' Energia ISO 50001:2011. (Corso accreditato AICQ-SICEV)
-
–
Abilitazione all’esercizio della professione di assistente farmacista in Australia.
Svolgimento del corso ‘The Fundamental of Community Pharmacy’ e conseguimento del ‘Certificate II in Community Pharmacy’. Come parte integrante di tale corso sono state svolte 38 ore di tirocinio formativo in una farmacia comunale (Priceline Pharmacy, 120 Queen St, Brisbane QLD 4000, Australia). -
–
Activities and Societies: Dal 2006 a Marzo 2012 Università degli Studi di Parma - Facoltà di Farmacia – Corso di laurea Specialistica in Chimica e Tecnologia Farmaceutiche.
Sostenuta tesi sperimentale di 8 mesi presso il dipartimento di Biochimica e Biologia molecolare. Tesi di Laurea in Biochimica dal titolo: “Chinurenina aminotransferasi II umana: valutazione di inibitori come potenziali agenti terapeutici di malattie neurologiche” . Requisiti tecnici: Abilità in
SDS-PAGE, isoelectric focusing, immunodetection con anticorpi, valutazione di cinetiche enzimatiche mediante uso di spettrofotometro, studio di spettri NMR e CMR, utilizzo HPLC.
Auszeichnungen/Preise
-
Winner of the first annual Pfizer Case Competition
Pfizer
Development of a viable plan of action for a pharmaceutical company engaged with the Italian National Health System and health sector.
Erhaltene Empfehlungen
1 Person hat Eugenio Rizzello empfohlen
Jetzt anmelden und ansehenWeitere Aktivitäten von Eugenio Rizzello
-
We’re excited to share that the FDA has approved NexoBrid® for treating pediatric patients with severe burns! Now, #NexoBrid is available for…
We’re excited to share that the FDA has approved NexoBrid® for treating pediatric patients with severe burns! Now, #NexoBrid is available for…
Beliebt bei Eugenio Rizzello
-
We are excited to announce the positive results from the U.S. NexoBrid® Expanded Access Protocol (NEXT) Since its initiation in 2019, NEXT has…
We are excited to announce the positive results from the U.S. NexoBrid® Expanded Access Protocol (NEXT) Since its initiation in 2019, NEXT has…
Beliebt bei Eugenio Rizzello
-
We are excited to share that our #EscharEx® ChronEx Phase II Study in Wound Care has been published in eClinicalMedicine, a prestigious journal…
We are excited to share that our #EscharEx® ChronEx Phase II Study in Wound Care has been published in eClinicalMedicine, a prestigious journal…
Beliebt bei Eugenio Rizzello
-
Another exciting opportunity at Ovivo! Dive in - Apply Today! Let's change the future of water together.
Another exciting opportunity at Ovivo! Dive in - Apply Today! Let's change the future of water together.
Beliebt bei Eugenio Rizzello
-
Italy's AIFA Agenzia Italiana del farmaco has cleared its backlog of reimbursement procedures, aims to shorten approval times, and has proposed the…
Italy's AIFA Agenzia Italiana del farmaco has cleared its backlog of reimbursement procedures, aims to shorten approval times, and has proposed the…
Beliebt bei Eugenio Rizzello
-
Experts Giuseppe Gulotta, Ph.D and Catia Proenca answer your frequently asked questions about the opportunity for RWE to impact market access for…
Experts Giuseppe Gulotta, Ph.D and Catia Proenca answer your frequently asked questions about the opportunity for RWE to impact market access for…
Beliebt bei Eugenio Rizzello